No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:

Simultaneous determination of N(1)-acetyl sulfisoxazole and its metabolites, and relative bioavailability compare to sulfisoxazole in rats.

Kim Eunyoung, Kang Wonku · J Pharm Biomed Anal · 2016

PMID: 27423008Observational

Interfacial engineering of hematite trigger periodate activation reaction for sustainable sulfisoxazole removal: Mechanism insight and environmental significance enhancement.

Dong Zheng-Tao, Sui Long, Yang Ya-Ya et al. · J Hazard Mater · 2026

PMID: 41435663Other

Electrical activation of periodate by nano-zero-valent cobalt/nitrogen-doped carbon for sulfisoxazole degradation: Insights into rapid electron transfer mechanisms.

Liu Yu, Liu Meng, Li Xiaoping et al. · J Colloid Interface Sci · 2025

PMID: 39870003Other

Unbound free fatty acids from intralipid displace bilirubin from albumin, comparable to sulfisoxazole.

Hegyi Thomas, Huber Andrew, Oh William et al. · Pediatr Res · 2025

PMID: 41331368Other

Harnessing CuCoO-Modified copper phenylacetylene for enhanced activation of peroxymonosulfate in non-radical sulfisoxazole degradation: Performance, pathways, and mechanisms.

Li Wenjun, Li Daguang, Lin Zili et al. · Environ Pollut · 2025

PMID: 39667576Other

Innovative spherical Fe-Mn layered double hydroxides (LDH) for the degradation of sulfisoxazole through activated periodate: Efficacy and mechanistic insights.

Jian Junle, Zhang Siling, Chen Ping et al. · Environ Pollut · 2025

PMID: 39732282Other

N-coordinated iron sites dispersed in porous carbon frameworks to activate peroxymonosulfate for efficient sulfisoxazole degradation and real hospital wastewater decontamination.

Yu Chunxiu, Gu Lingyun, Wu Zelin et al. · J Hazard Mater · 2024

PMID: 39423642Other

Novel bis-ureido-substituted sulfaguanidines and sulfisoxazoles as carbonic anhydrase and acetylcholinesterase inhibitors.

Lolak Nebih, Akocak Süleyman, Durgun Mustafa et al. · Mol Divers · 2023

PMID: 36136229Other

Carbocatalysts for Enhancing Permanganate Oxidation of Sulfisoxazole.

Wang Dingxiang, Ma Jun, Zhang Jing et al. · Environ Sci Technol · 2023

PMID: 36727553Other

A visualization and fluorimetric detection for sulfisoxazole based on selectively weakened peroxidase activity of gold nanoclusters.

Li Meiling, Hong Nanping, Peng Huaidong et al. · J Pharm Biomed Anal · 2026

PMID: 41232433Preclinical

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type: Substance / Medication
Fully Specified Name: Sulfafurazole (substance)
SNOMED CT: 372858002
UMLS CUI: C0038745
RxNorm CUI: 10207

Clinical Data

This intervention maps to 8 entities in the Ltrl knowledge graph.

Conditions

Biomarkers

Specialists

Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.